MADISON, N.J., March 3 /PRNewswire-FirstCall/ -- Wyeth announced today that it will present at the SG Cowen & Co. 26th Annual Healthcare Conference on Tuesday, March 7, 2006 at 8:50 a.m. Eastern Time. Presenting for Wyeth will be Mary Katherine Wold, Senior Vice President - Tax and Treasury, Wyeth.
Wyeth’s presentation will be webcast live for investors at http://www.wyeth.com and available for replay following the conference.
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
The statements in this press release that are not historical facts are forward-looking statements based on current expectations of future events that involve risks and uncertainties including, without limitation, risks associated with the inherent uncertainty of the timing and success of pharmaceutical research, product development, manufacturing, commercialization, economic conditions including interest and currency exchange rate fluctuations, changes in generally accepted accounting principles, the impact of competitive or generic products, trade buying patterns, wars or terrorist acts, product liability and other types of lawsuits, the impact of legislation and regulatory compliance and obtaining reimbursement, favorable drug pricing, access and other approvals, environmental liabilities, and patent, and other risks and uncertainties, including those detailed from time to time in the Company’s periodic reports, including current reports on Form 8-K, quarterly reports on Form 10-Q and the annual report on Form 10-K, filed with the Securities and Exchange Commission. Actual results may vary materially from the forward-looking statements. The Company assumes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
Wyeth
CONTACT: Media: Douglas Petkus, +1-973-660-5218; or Investors: JustinVictoria, +1-973-660-5340, both of Wyeth
Web site: http://www.wyeth.com/
